TNP-351 | Interleukin Related interleukin-related.com

Product Name :
TNP-351

Search keywords :
TNP-351

drugId :
null

Target Vo:
Dihydrofolate reductase

Target Vo Short Name :
DHFR

Moa_Name:
Dihydrofolate reductase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Takeda

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Neoplasms

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Retinoid X Receptor alpha Antibody
IKK gamma Antibody
Dnmt1 Antibody (YA476): Dnmt1 Antibody (YA476) is a non-conjugated and Rabbit origined monoclonal antibody about 183 kDa, targeting to Dnmt1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts